pneumocysti
pneumonia
pcp
contemporari
pneumocysti
primari
infect
well
recogn
import
caus
morbid
mortal
prematur
infant
weaken
children
sinc
least
sinc
pcp
also
occur
immunosuppress
infant
children
mostli
human
immunodefici
viru
hiv
infect
specif
develop
contrast
seroepidemiolog
survey
conduct
suggest
first
contact
fungu
occur
nonimmunosuppress
infant
two
year
begin
microbiolog
data
clinic
profil
relat
primari
infect
nonimmunosuppress
infant
thought
essenti
fact
studi
varga
colleagu
nevez
colleagu
show
primari
infect
nonimmunosuppress
infant
symptomat
associ
viral
bacteri
later
larsen
colleagu
report
primari
infect
occur
contemporari
selflimit
upper
respiratori
tract
infect
urti
avail
data
p
jirovecii
genom
characterist
infant
develop
primari
infect
limit
wherea
p
jirovecii
genotyp
mostli
identifi
pcp
adult
totet
colleagu
shown
genotyp
p
jirovecii
organ
involv
primari
infect
nonimmunosuppress
infant
pcp
adult
similar
suggest
popul
part
common
convers
beard
colleagu
suggest
circul
transmiss
fungu
two
popul
occur
nonetheless
due
method
discrep
result
still
subject
debat
may
clinic
profil
microbiolog
p
jirovecii
genom
characterist
relat
primari
infect
still
poorli
understood
context
object
present
studi
detect
p
jirovecii
cohort
infant
risk
primari
infect
ii
correl
presenc
infant
characterist
iii
identifi
p
jirovecii
genotyp
unilocu
bilocu
multilocu
sequenc
type
mlst
approach
infant
popul
compar
found
pcp
adult
popul
monitor
geograph
area
one
hundr
ninetytwo
nonimmunosuppress
infant
sex
ratio
mf
median
age
day
limit
day
retrospect
enrol
infant
initi
admit
brest
univers
hospit
franc
april
juli
submit
nasopharyng
aspir
npa
infant
npa
viral
diagnosi
within
framework
investig
pulmonari
symptom
fever
nucleic
acid
npa
extract
use
store
examin
control
p
jirovecii
detect
retrospect
perform
npa
use
realtim
quantit
polymeras
chain
reaction
qpcr
assay
target
mitochondri
larg
subunit
ribosom
rna
mtlsurrna
describ
elsewher
real
time
pcr
system
appli
biosystem
foster
citi
ca
usa
primari
infect
defin
detect
p
jirovecii
npa
sampl
infant
infant
priori
immunena
p
jirovecii
twentyon
adult
pcp
sex
ratio
mf
median
age
year
limit
year
retrospect
enrol
also
monitor
brest
univers
hospit
submit
bronchoalveolar
lavag
bal
procedur
pcp
diagnosi
twentyon
bal
specimen
examin
contemporan
infant
npa
examin
januari
octob
p
jirovecii
detect
use
microscop
examin
indirect
immunofluoresc
assay
biorad
marneslacoquett
franc
aforement
qpcr
assay
describ
popul
repres
control
popul
pneumocysti
genotyp
avoid
contamin
step
pcr
assay
perform
differ
area
laboratori
differ
set
micropipett
mix
reagent
prepar
laminar
flow
cabinet
monitor
possibl
contamin
neg
control
includ
experi
pcr
round
extract
dna
posit
npa
infant
bal
sampl
adult
examin
pneumocysti
genotyp
base
unilocu
bilocu
multilocu
sequenc
type
mlst
method
three
loci
mtlsurrna
cytochrom
b
cyb
superoxid
dismutas
sod
gene
analyz
previous
first
singleround
pcr
perform
locu
describ
nest
pcr
perform
sod
locu
previous
describ
sampl
fail
give
amplif
singleround
pcr
discriminatori
power
determin
use
hunter
index
h
discriminatori
power
consid
good
h
prevent
cross
contamin
pcr
sequenc
assay
genotyp
done
describ
moreov
assay
perform
differ
laboratori
one
p
jirovecii
infect
diagnosi
initi
perform
two
laboratori
locat
differ
hospit
site
infant
adult
sociodemograph
clinic
data
collect
use
brest
univers
hospit
onlin
softwar
portail
informatis
du
processu
de
soin
ip
statist
analys
perform
use
prism
softwar
version
graphpad
softwar
san
diego
ca
usa
xlstat
softwar
version
addinsoft
brooklyn
ny
usa
qualit
variabl
compar
use
fisher
exact
test
test
appropri
quantit
variabl
compar
use
mannwhitney
test
twosid
pvalu
consid
signific
logist
regress
use
univari
multivari
analys
studi
nonintervent
requir
inform
consent
ethic
approv
accord
french
law
regul
csp
art
p
jirovecii
detect
infant
npa
result
p
jirovecii
detect
infant
characterist
shown
tabl
first
approach
qualit
data
analysi
use
fisher
exact
test
point
follow
characterist
infant
age
p
underli
diseas
p
hospit
discharg
birth
p
inde
newborn
infant
hospit
birth
discharg
mother
univari
multivari
analys
logist
regress
shown
tabl
univari
analysi
point
follow
factor
posit
associ
p
jirovecii
detect
distribut
age
group
specif
group
third
quartil
p
ic
group
p
ic
congenit
diseas
p
ic
viral
infect
p
ic
lower
respiratori
tract
infect
p
ic
univari
analysi
point
follow
factor
neg
associ
p
jirovecii
detect
hyalin
membran
diseas
andor
bronchopulmonari
dysplasia
p
ic
absenc
hospit
discharg
birth
p
ic
among
aforement
factor
multivari
analysi
retain
two
factor
group
p
ic
absenc
hospit
discharg
birth
p
ic
result
genotyp
detail
tabl
take
result
p
jirovecii
type
infant
adult
togeth
hunter
index
unilocu
approach
base
mtlsu
cyb
sod
gene
hunter
index
bilocu
genotyp
method
mlst
respect
infant
popul
consid
mtlsu
cyb
sod
allel
previous
describ
elsewher
three
mtlsu
allel
identifi
frequent
infant
five
cyb
allel
identifi
frequent
infant
two
sod
allel
identifi
frequent
allel
seven
infant
bilocu
type
system
base
analysi
mtlsu
locu
combin
cyb
locu
enabl
us
identifi
seven
mtlsucyb
genotyp
infant
frequent
three
infant
use
mlst
seven
genotyp
identifi
six
infant
adult
popul
four
mtlsu
allel
identifi
frequent
seven
adult
addit
six
cyb
allel
identifi
frequent
adult
three
sod
allel
identifi
frequent
adult
bilocu
type
locu
permit
identifi
mtlsucyb
genotyp
frequent
three
adult
respect
twelv
mlst
genotyp
also
identifi
three
found
two
adult
nine
other
found
one
adult
among
four
mtlsu
allel
identifi
adult
wherea
three
other
identifi
infant
adult
among
seven
cyb
allel
identifi
infant
wherea
identifi
adult
two
major
cyb
allel
share
two
popul
among
three
sod
allel
identifi
adult
wherea
two
other
share
two
popul
five
bilocu
genotyp
common
popul
wherea
two
genotyp
found
infant
nine
genotyp
exclus
found
adult
total
mlst
genotyp
identifi
none
share
two
patient
popul
detect
p
jirovecii
infant
former
studi
detect
infant
result
obtain
year
apart
two
similar
infant
popul
two
french
region
km
apart
differ
significantli
p
p
jirovecii
presenc
detect
infant
definit
child
less
year
old
consid
relat
first
contact
fungu
consequ
contemporari
primari
infect
definit
primari
infect
could
discuss
put
p
jirovecii
reinfect
could
strictli
rule
case
noteworthi
p
jirovecii
mainli
detect
young
infant
four
infant
year
old
thu
concept
reinfect
p
jirovecii
remain
specul
infant
enrol
studi
may
present
pulmonari
colon
pcp
nonetheless
hypothesi
pcp
develop
improb
sinc
recov
without
specif
treatment
infect
due
virus
associ
factor
presenc
p
jirovecii
expect
sinc
infant
enrol
present
studi
mostli
present
bronchiol
pulmonari
syndrom
specif
relat
virus
moreov
previous
describ
report
microbi
present
studi
p
jirovecii
detect
appar
absenc
pathogen
infant
suggest
fungu
may
play
role
pulmonari
syndrom
pathogenesi
nonetheless
posit
infant
recov
despit
absenc
specif
treatment
fungu
hypothes
presenc
p
jirovecii
follow
clinic
improv
could
explain
immunena
statu
infant
one
hand
role
symptomat
treatment
physiotherapi
absenc
overt
immunosuppress
hand
contrari
larsen
colleagu
studi
p
jirovecii
detect
specif
associ
urti
studi
lower
respiratori
tract
infect
lrti
appear
associ
result
consist
fact
p
jirovecii
infect
effect
take
place
deep
within
lung
specif
alveoli
close
contact
type
primari
infect
contemporari
first
contact
fungu
may
present
mild
lrti
identifi
prematur
factor
associ
p
jirovecii
nonetheless
p
jirovecii
detect
preterm
infant
wherea
roja
et
al
sevil
spain
recent
detect
fungu
preterm
infant
discrep
result
versu
p
probabl
due
differ
sampl
method
differ
hospit
locat
brest
brittani
franc
versu
sevil
andalusia
spain
geograph
differ
p
jirovecii
epidemiolog
europ
previous
report
patient
chronic
pulmonari
may
result
combin
roja
colleagu
obtain
french
spanish
popul
respect
show
p
jirovecii
still
involv
nonimmunosuppress
preterm
infant
europ
describ
import
find
alreadi
publish
separ
correspond
arous
interest
congenit
diseas
appear
associ
factor
tabl
best
knowledg
none
associ
overt
immunosuppress
nonetheless
associ
provid
addit
argument
wellrecogn
link
p
jirovecii
infant
hyalin
membran
diseas
bronchopulmonari
dysplasia
factor
neg
associ
p
jirovecii
detect
neg
associ
remain
unclear
may
explain
fact
identifi
prematur
associ
factor
wherea
assum
relationship
prematur
hyalin
membran
diseas
bronchopulmonari
univari
analysi
point
absenc
hospit
discharg
birth
factor
neg
associ
p
jirovecii
detect
result
confirm
multivari
analysi
thu
p
jirovecii
mostli
acquir
commun
infant
left
hospit
birth
contrast
p
jirovecii
found
two
infant
left
hospit
birth
result
expect
sinc
infant
stay
hospit
birth
younger
discharg
median
age
day
interquartil
rang
iqr
vs
median
age
day
iqr
nonetheless
p
jirovecii
acquisit
happen
within
hospit
premis
potenti
human
sourc
health
care
worker
patient
mother
remain
undetermin
case
sum
result
support
possibl
commun
nosocomi
acquisit
fungu
also
context
primari
infect
infant
previous
shown
pcp
immunosuppress
multivari
analysi
also
identifi
group
factor
associ
p
jirovecii
detect
median
age
posit
infant
month
day
iqr
day
wherea
month
iqr
month
month
iqr
day
month
month
chile
denmark
peru
respect
ochoa
tj
bustamant
b
garcia
c
al
manuscript
prepar
studi
report
year
ago
median
age
posit
infant
month
iqr
month
figur
compar
result
aforement
studi
must
done
cautious
nonetheless
valu
median
iqr
age
posit
infant
close
common
characterist
suggest
first
contact
p
jirovecii
consequ
primari
infect
infant
common
process
occur
time
life
regardless
geograph
locat
rather
incident
event
analysi
p
jirovecii
detect
result
infant
chile
denmark
peru
franc
point
signific
differ
preval
p
higher
preval
south
america
europ
figur
ochoa
tj
bustamant
b
garcia
c
al
manuscript
prepar
beyond
differ
method
result
may
relat
genuin
geograph
specif
pneumocysti
epidemiolog
hypothesi
previous
assum
explain
differ
pneumocysti
colon
preval
patient
chronic
pulmonari
consid
maitt
colleagu
propos
p
jirovecii
genotyp
skill
area
chose
analyz
mtlsu
cyb
sod
discriminatori
power
type
system
increas
unilocu
approach
bilocu
approach
mlst
method
result
expect
consid
recommend
mlst
microorgan
type
method
publish
appar
divers
p
jirovecii
grew
accord
increas
discriminatori
power
type
method
use
consequ
unilocu
bilocu
approach
show
genotyp
common
infant
adult
wherea
mlst
genotyp
share
appar
contradictori
result
due
technolog
constraint
make
imposs
conclud
whether
acquisitiontransmiss
cycl
p
jirovecii
primari
infect
infant
pcp
adult
independ
result
mlst
suggest
put
correl
specif
genotyp
clinic
present
primari
infect
infant
versu
pcp
adult
hypothesi
rule
sinc
one
mlst
genotyp
identifi
infant
popul
also
identifi
maitt
colleagu
among
adult
develop
pcp
monitor
anoth
french
univers
hospit
noteworthi
genotyp
two
posit
infant
left
hospit
birth
differ
infant
discharg
birth
tabl
observ
consist
differ
sourc
p
jirovecii
twoinfant
popul
howev
genotyp
result
conclus
consid
low
number
patient
mlst
success
pcp
adult
six
infant
tabl
studi
present
limit
retrospect
approach
enrol
symptomat
infant
examin
npa
infant
bal
specimen
adult
nonetheless
investig
infant
popul
brittani
franc
combin
result
metaanalysi
avail
data
anoth
french
region
chile
denmark
peru
show
despit
put
geograph
specif
pneumocysti
primari
infect
nonimmunosuppress
infant
appear
common
event
occur
worldwid
